Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Lyvgen Biopharma Initiates Phase II Study for LVGN7409 in Advanced NSCLC
January 30, 2025
Company
Deals
ZSHK Laboratories Raises RMB 100 Million in Series B Financing Round
January 30, 2025
Company
Ascentage Pharma Receives Drug Production License for Suzhou Plant
January 30, 2025
Company
Drug
Everest Medicines’ Nefecon Gains Accelerated Approval in Taiwan and South Korea
January 30, 2025
Company
Taizhou-Wuxi-Lianyungang Biomedicine Hub Launched at China Medical Expo
January 30, 2025
Company
Deals
Huadong Medicine Partners with Dongyang Med for Equity Collaboration
January 30, 2025
Company
Drug
Jiangsu Hengrui Gets NMPA Approval for HR20031 Clinical Study in Type 2 Diabetes
January 30, 2025
Drug
Fosun Pharma’s Henlius Completes Clinical Trial Filing for HLX301 in Australia
January 30, 2025
Company
Medical Device
Peijia Medical Announces First Patient Implant in MonarQ TTVR System Clinical Study
January 30, 2025
Company
Deals
Zhejiang Dian Diagnostics Partners with Chengdu Eastern New Area for IVD Hub
January 30, 2025
Company
Deals
Anyeep Raises RMB 100 Million in Series A Financing for Mass Spectrometry Development
January 30, 2025
Company
Deals
Shanghai Henlius Biotech to Provide R&D Services for COVID-19 Therapy Azvudine
January 30, 2025
1
2
3
4
5
…
24
25
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
